查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1786787

非小细胞肺癌(NSCLC)的全球市场，规模，占有率，趋势，产业分析报告:类别，不同治疗，各流通管道，各地区 - 市场预测，2025年～2034年

Non-Small Cell Lung Cancer Market Size, Share, Trends, & Industry Analysis Report By Type, By Treatment (Chemotherapy, Targeted Therapy, Immunotherapy, and Others), By Distribution Channel, and By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，预计到 2034 年，非小细胞肺癌 (NSCLC) 市场规模将达到 1,298.8 亿美元。本报告深入分析了当前的市场动态，并分析了未来的市场成长。

非小细胞肺癌 (NSCLC) 占全球肺癌病例的大多数，并正在推动精准肿瘤学的发展。生物标记检测、标靶疗法和免疫疗法的日益普及正在重塑治疗方法，而液体活检和突变特异性药物的创新则有助于实现早期诊断并改善疗效。

市场成长主要得益于全球非小细胞肺癌 (NSCLC) 盛行率的上升、标靶治疗和免疫疗法的日益普及，以及伴随诊断在支持个人化治疗方案方面的日益普及。

非小细胞肺癌 (NSCLC) 市场报告重点

按类型划分，腺癌因其高盛行率和对标靶治疗方案的强烈反应，在 2024 年占据了市场占有率的主导地位。

按治疗类型划分，标靶治疗在 2024 年占据了市场主导地位，这得益于 EGFR、ALK 和 KRAS 抑制剂在临床上的广泛应用。

按分销管道划分，医院药房在 2024 年占据了市场主导地位，因为医院药房可以集中获取晚期癌症治疗药物并进行临床监管。

受分子诊断的早期应用和对新型疗法的监管支持的推动，到2024年，北美将占据全球非小细胞肺癌 (NSCLC) 市场的大部分占有率。

由于癌症发生率上升、医疗保健可及性的扩大以及对肿瘤学研究的投资增加，预计亚太地区在预测期内将以最快的复合年增长率增长。

全球主要市场参与者：罗氏控股公司、阿斯特捷利康公司、默克公司等。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球非小细胞肺癌(NSCLC)市场洞察

  • 市场概述
  • 非小细胞肺癌(NSCLC)市场动态
    • 促进因素和机会
      • 全球非小细胞肺癌 (NSCLC) 病例激增
      • 液体活检和多重检测的临床应用日益增加平台
    • 限制与课题
      • 先进诊断工具的高成本
  • PESTEL分析
  • 非小细胞肺癌(NSCLC)市场趋势
  • 价值链分析

第5章 全球非小细胞肺癌(NSCLC)市场:类别

  • 主要调查结果
  • 简介
  • 扁平表皮癌症
  • 大细胞癌症
  • 腺癌症
  • 其他

第6章 全球非小细胞肺癌(NSCLC)市场:不同治疗

  • 主要调查结果
  • 简介
  • 化疗
  • 标靶治疗
  • 免疫疗法
  • 其他

第7章 全球非小细胞肺癌(NSCLC)市场:各流通管道

  • 主要调查结果
  • 简介
  • 医院药局
  • 药妆店·零售药局
  • 线上药局

第8章 全球非小细胞肺癌(NSCLC)市场:各地区

  • 主要调查结果
  • 简介
    • 非小细胞肺癌(NSCLC)市场评估:各地区，2020年～2034年
  • 北美
    • 北美:类别，2020～2034年
    • 北美:不同治疗，2020～2034年
    • 北美:各流通管道，2020～2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:类别，2020～2034年
    • 欧洲:不同治疗，2020～2034年
    • 欧洲:各流通管道，2020～2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:类别，2020～2034年
    • 亚太地区:不同治疗，2020～2034年
    • 亚太地区:各流通管道，2020～2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:类别，2020～2034年
    • 中东·非洲:不同治疗，2020～2034年
    • 中东·非洲:各流通管道，2020～2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东·非洲
  • 南美
    • 南美:类别，2020-2034年
    • 南美:不同治疗，2020-2034年
    • 南美:各流通管道，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第9章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第10章 企业简介

  • Amgen Inc.
  • AstraZeneca PLC
  • Beigene Ltd.
  • Bristol-Myers Squibb Company
  • Eli Lilly And Company
  • Exelixis Inc.
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Mirati Therapeutics Inc.
  • Novartis AG
  • Pfizer Inc.
  • Roche Holding AG
Product Code: PM6101

The non-small cell lung cancer market size is expected to reach USD 129.88 Billion by 2034, according to a new study by Polaris Market Research. The report "Non-Small Cell Lung Cancer Market Share, Size, Trends, Industry Analysis Report: By Type, By Treatment (Chemotherapy, Targeted Therapy, Immunotherapy, and Others), By Distribution Channel, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Non-small cell lung cancer (NSCLC) represents the majority of global lung cancer cases and is driving advances in precision oncology. Increasing use of biomarker testing, targeted therapies, and immunotherapies is reshaping treatment approaches, while innovations in liquid biopsy and mutation-specific drugs are enabling earlier diagnosis and better outcomes.

Market growth is primarily driven by the rising global incidence of NSCLC, increasing adoption of targeted and immune-based therapies and the growing availability of companion diagnostics that support personalized treatment plans.

Non-Small Cell Lung Cancer Market Report Highlights

Based on type, the adenocarcinoma segment dominated the market share in 2024, driven by its high prevalence and strong response to targeted therapy options.

In terms of treatment, the targeted therapy segment dominated the market in 2024, supported by the broad clinical use of EGFR, ALK, and KRAS inhibitors.

Based on distribution channel, the hospital pharmacy segment dominated the market in 2024, due to centralized access to advanced oncology drugs and clinical oversight.

North America accounted for the majority share in the global non-small cell lung cancer market in 2024, driven by early adoption of molecular diagnostics and regulatory support for novel therapies.

Asia Pacific is projected to grow at the fastest CAGR during the forecast period, owing to rising cancer incidence, expanding healthcare access, and growing investment in oncology research.

A few global key market players include Roche Holding AG, AstraZeneca PLC, Merck & Co., Inc., Bristol-Myers Squibb Company, Pfizer Inc., Eli Lilly And Company, Novartis AG, Johnson & Johnson, Amgen Inc., Beigene Ltd., Exelixis Inc., and Mirati Therapeutics Inc.

Polaris Market Research has segmented the market report on the basis of type, treatment, distribution channel, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

Squamous Cell Carcinoma

Large Cell Carcinoma

Adenocarcinoma

Other Type

By Treatment Outlook (Revenue, USD Billion, 2020-2034)

Chemotherapy

Targeted Therapy

Immunotherapy

Others

By Distribution Channel Outlook (Revenue, USD Billion, 2020-2034)

Hospital Pharmacy

Drug Store and Retail Pharmacy

Online Pharmacy

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Non-Small Cell Lung Cancer Market Insights

  • 4.1. Non-Small Cell Lung Cancer Market - Market Snapshot
  • 4.2. Non-Small Cell Lung Cancer Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rapidly Rising Cases of NSCLC Globally
      • 4.2.1.2. Increasing Clinical Adoption of Liquid Biopsies and Multiplexed Testing Platforms
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Costs Associated with Advanced Diagnostic Tools
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Non-Small Cell Lung Cancer Market Trends
  • 4.6. Value Chain Analysis

5. Global Non-Small Cell Lung Cancer Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • 5.3. Squamous Cell Carcinoma
    • 5.3.1. Global Non-Small Cell Lung Cancer Market, by Squamous Cell Carcinoma, by Region, 2020-2034 (USD Billion)
  • 5.4. Large Cell Carcinoma
    • 5.4.1. Global Non-Small Cell Lung Cancer Market, by Large Cell Carcinoma, by Region, 2020-2034 (USD Billion)
  • 5.5. Adenocarcinoma
    • 5.5.1. Global Non-Small Cell Lung Cancer Market, by Adenocarcinoma, by Region, 2020-2034 (USD Billion)
  • 5.6. Other Type
    • 5.6.1. Global Non-Small Cell Lung Cancer Market, by Other Type, by Region, 2020-2034 (USD Billion)

6. Global Non-Small Cell Lung Cancer Market, by Treatment

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • 6.3. Chemotherapy
    • 6.3.1. Global Non-Small Cell Lung Cancer Market, by Chemotherapy, by Region, 2020-2034 (USD Billion)
  • 6.4. Targeted Therapy
    • 6.4.1. Global Non-Small Cell Lung Cancer Market, by Targeted Therapy, by Region, 2020-2034 (USD Billion)
  • 6.5. Immunotherapy
    • 6.5.1. Global Non-Small Cell Lung Cancer Market, by Immunotherapy, by Region, 2020-2034 (USD Billion)
  • 6.6. Others
    • 6.6.1. Global Non-Small Cell Lung Cancer Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Non-Small Cell Lung Cancer Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.3. Hospital Pharmacy
    • 7.3.1. Global Non-Small Cell Lung Cancer Market, by Hospital Pharmacy, by Region, 2020-2034 (USD Billion)
  • 7.4. Drug Store and Retail Pharmacy
    • 7.4.1. Global Non-Small Cell Lung Cancer Market, by Drug Store and Retail Pharmacy, by Region, 2020-2034 (USD Billion)
  • 7.5. Online Pharmacy
    • 7.5.1. Global Non-Small Cell Lung Cancer Market, by Online Pharmacy, by Region, 2020-2034 (USD Billion)

8. Global Non-Small Cell Lung Cancer Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Non-Small Cell Lung Cancer Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Non-Small Cell Lung Cancer Market - North America
    • 8.3.1. North America: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
    • 8.3.3. North America: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.3.4. Non-Small Cell Lung Cancer Market - U.S.
      • 8.3.4.1. U.S.: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.3.5. Non-Small Cell Lung Cancer Market - Canada
      • 8.3.5.1. Canada: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.4. Non-Small Cell Lung Cancer Market - Europe
    • 8.4.1. Europe: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.4. Non-Small Cell Lung Cancer Market - UK
      • 8.4.4.1. UK: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.5. Non-Small Cell Lung Cancer Market - France
      • 8.4.5.1. France: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.6. Non-Small Cell Lung Cancer Market - Germany
      • 8.4.6.1. Germany: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.7. Non-Small Cell Lung Cancer Market - Italy
      • 8.4.7.1. Italy: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.8. Non-Small Cell Lung Cancer Market - Spain
      • 8.4.8.1. Spain: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.9. Non-Small Cell Lung Cancer Market - Netherlands
      • 8.4.9.1. Netherlands: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.10. Non-Small Cell Lung Cancer Market - Russia
      • 8.4.10.1. Russia: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.11. Non-Small Cell Lung Cancer Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.5. Non-Small Cell Lung Cancer Market - Asia Pacific
    • 8.5.1. Asia Pacific: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.4. Non-Small Cell Lung Cancer Market - China
      • 8.5.4.1. China: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.5. Non-Small Cell Lung Cancer Market - India
      • 8.5.5.1. India: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.6. Non-Small Cell Lung Cancer Market - Malaysia
      • 8.5.6.1. Malaysia: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.7. Non-Small Cell Lung Cancer Market - Japan
      • 8.5.7.1. Japan: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.8. Non-Small Cell Lung Cancer Market - Indonesia
      • 8.5.8.1. Indonesia: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.9. Non-Small Cell Lung Cancer Market - South Korea
      • 8.5.9.1. South Korea: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.10. Non-Small Cell Lung Cancer Market - Australia
      • 8.5.10.1. Australia: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.11. Non-Small Cell Lung Cancer Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.6. Non-Small Cell Lung Cancer Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.4. Non-Small Cell Lung Cancer Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.5. Non-Small Cell Lung Cancer Market - UAE
      • 8.6.5.1. UAE: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.6. Non-Small Cell Lung Cancer Market - Israel
      • 8.6.6.1. Israel: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.7. Non-Small Cell Lung Cancer Market - South Africa
      • 8.6.7.1. South Africa: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.8. Non-Small Cell Lung Cancer Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.7. Non-Small Cell Lung Cancer Market - Latin America
    • 8.7.1. Latin America: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.4. Non-Small Cell Lung Cancer Market - Mexico
      • 8.7.4.1. Mexico: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.5. Non-Small Cell Lung Cancer Market - Brazil
      • 8.7.5.1. Brazil: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.6. Non-Small Cell Lung Cancer Market - Argentina
      • 8.7.6.1. Argentina: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.7. Non-Small Cell Lung Cancer Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Amgen Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. AstraZeneca PLC
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Beigene Ltd.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Bristol-Myers Squibb Company
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Eli Lilly And Company
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Exelixis Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Johnson & Johnson
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Merck & Co., Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Mirati Therapeutics Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Novartis AG
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Pfizer Inc.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Roche Holding AG
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development

List of Tables:

  • Table 1 Global Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 2 Global Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 3 Global Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 4 North America: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 5 North America: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 6 North America: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 7 U.S.: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 8 U.S.: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 9 U.S.: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 10 Canada: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 11 Canada: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 12 Canada: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 13 Europe: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 14 Europe: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 15 Europe: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 16 UK: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 17 UK: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 18 UK: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 19 France: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 20 France: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 21 France: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 22 Germany: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 23 Germany: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 24 Germany: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 25 Italy: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 26 Italy: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 27 Italy: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 28 Spain: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 29 Spain: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 30 Spain: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 34 Russia: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 35 Russia: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 36 Russia: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 43 China: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 44 China: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 45 China: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 46 India: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 47 India: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 48 India: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 52 Japan: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 53 Japan: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 54 Japan: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 58 South Korea: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 59 South Korea: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 60 South Korea: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 61 Australia: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 62 Australia: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 63 Australia: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 73 UAE: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 74 UAE: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 75 UAE: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 76 Israel: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 77 Israel: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 78 Israel: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 79 South Africa: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 80 South Africa: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 81 South Africa: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 85 Latin America: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 86 Latin America: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 87 Latin America: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 88 Mexico: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 89 Mexico: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 90 Mexico: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 91 Brazil: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 92 Brazil: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 93 Brazil: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 94 Argentina: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 95 Argentina: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 96 Argentina: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Non-Small Cell Lung Cancer Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Non-Small Cell Lung Cancer Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Treatment
  • Figure 9. Global Non-Small Cell Lung Cancer Market, by Treatment, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Non-Small Cell Lung Cancer Market, by Distribution Channel, 2024 & 2034 (USD Billion)